Bustamante, Regine Fher S.

HRN: 21-22-80  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2023
CEFTAZIDIME 1GM (VIAL)
10/20/2023
10/26/2023
IV
450mg
Q8h
Sepsis
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: